Keywords: imclone, starts, ph, ii, enrollment, imc-a12, drug

ImClone starts Ph II enrollment for IMC-A12

Article | 23 July 2007

Print This

US drug developer ImClone Systems says that the first of its Phase II clinical trials with the anti-insulin-like growth factor-1 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in